NZ211440A - Dopamine-beta-hydroxylase inhibitors and pharmaceutical compositions - Google Patents

Dopamine-beta-hydroxylase inhibitors and pharmaceutical compositions

Info

Publication number
NZ211440A
NZ211440A NZ211440A NZ21144085A NZ211440A NZ 211440 A NZ211440 A NZ 211440A NZ 211440 A NZ211440 A NZ 211440A NZ 21144085 A NZ21144085 A NZ 21144085A NZ 211440 A NZ211440 A NZ 211440A
Authority
NZ
New Zealand
Prior art keywords
dopamine
beta
pharmaceutical compositions
hydroxylase inhibitors
hydroxylase
Prior art date
Application number
NZ211440A
Inventor
J S Frazee
C Kaiser
L I Kruse
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of NZ211440A publication Critical patent/NZ211440A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C07D239/40—One sulfur atom as doubly bound sulfur atom or as unsubstituted mercapto radical
NZ211440A 1984-03-19 1985-03-14 Dopamine-beta-hydroxylase inhibitors and pharmaceutical compositions NZ211440A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59066584A 1984-03-19 1984-03-19

Publications (1)

Publication Number Publication Date
NZ211440A true NZ211440A (en) 1988-09-29

Family

ID=24363168

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ222876A NZ222876A (en) 1984-03-19 1985-03-14 Intermediates of dopamine-beta-hydroxylase inhibitors
NZ211440A NZ211440A (en) 1984-03-19 1985-03-14 Dopamine-beta-hydroxylase inhibitors and pharmaceutical compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NZ222876A NZ222876A (en) 1984-03-19 1985-03-14 Intermediates of dopamine-beta-hydroxylase inhibitors

Country Status (9)

Country Link
KR (1) KR850006189A (en)
DK (2) DK118985A (en)
FI (1) FI83309C (en)
HU (1) HU194184B (en)
IL (1) IL74586A (en)
NO (1) NO162616C (en)
NZ (2) NZ222876A (en)
PH (1) PH21032A (en)
ZW (1) ZW4285A1 (en)

Also Published As

Publication number Publication date
NZ222876A (en) 1988-09-29
PH21032A (en) 1987-06-30
HU194184B (en) 1988-01-28
FI83309C (en) 1991-06-25
NO851056L (en) 1985-09-20
IL74586A0 (en) 1985-06-30
DK118985D0 (en) 1985-03-15
DK189691D0 (en) 1991-11-20
FI851073A0 (en) 1985-03-18
IL74586A (en) 1988-11-30
FI851073L (en) 1985-09-20
FI83309B (en) 1991-03-15
DK118985A (en) 1985-09-20
KR850006189A (en) 1985-10-02
NO162616C (en) 1990-01-24
HUT37602A (en) 1986-01-23
DK189691A (en) 1991-11-20
NO162616B (en) 1989-10-16
ZW4285A1 (en) 1985-06-26

Similar Documents

Publication Publication Date Title
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
NZ212005A (en) Pyrrolobenzimidazoles and pharmaceutical compositions
IL74758A (en) Acyltripeptides and pharmaceutical compositions containing them
GB8403359D0 (en) Pharmaceutical compositions
NZ212099A (en) Substituted arylhydroxamates and pharmaceutical compositions
NZ211031A (en) 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions
NZ211822A (en) Phenethanolamine derivatives and pharmaceutical compositions
GB2165451B (en) Pharmaceutical compositions
IL74865A0 (en) 9a-aza-9a-homoerythromycin derivatives and pharmaceutical compositions containing them
NZ201520A (en) Substituted aminopyridazines and pharmaceutical compositions
IL76188A (en) 3-aralkylidene-hydroxy-flavanone derivatives and pharmaceutical compositions containing them
GB8410289D0 (en) Pharmaceutical compositions
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
GB8403360D0 (en) Pharmaceutical compositions
NZ210818A (en) 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions
NZ209095A (en) Piperidinoquinazolines and pharmaceutical compositions
NZ212953A (en) 3-acyl-1-aminoalkyl-1h-indoles and pharmaceutical compositions thereof
GB2167414B (en) Flavolignan derivatives and pharmaceutical compositions containing them
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
NZ208244A (en) Phenyl-pyrazol-3-ones and pharmaceutical compositions
GB8409961D0 (en) Pharmaceutical compositions
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions
NZ214048A (en) Cephalosporins and pharmaceutical compositions
PH21779A (en) Sulfonomidines and pharmaceutical compositions containing the same